Results 61 to 70 of about 13,894,413 (409)

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Circulation
BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors ...
Seth S. Martin, A. Aday, Zaid I Almarzooq, Cheryl A M Anderson, Pankaj Arora, Christy L Avery, C. Baker-Smith, Bethany Barone Gibbs, Andrea Z Beaton, Amelia K Boehme, Yvonne Commodore-Mensah, Maria E Currie, Mitchell S. V. Elkind, K. Evenson, Giuliano Generoso, Debra G Heard, Swapnil Hiremath, Michelle C. Johansen, Rizwan Kalani, Dhruv S. Kazi, Darae Ko, Junxiu Liu, Jared W. Magnani, E. Michos, M. Mussolino, S. Navaneethan, N. Parikh, Sarah M Perman, Remy Poudel, M. Rezk-Hanna, Gregory A. Roth, Nilay S Shah, M. St-Onge, Evan L. Thacker, C. Tsao, Sarah M. Urbut, H. V. Van Spall, Jenifer H. Voeks, Nae-Yuh Wang, Nathan D. Wong, Sally S Wong, Kristine Yaffe, Latha P. Palaniappan   +42 more
semanticscholar   +1 more source

Circulating histones as clinical biomarkers in critically ill conditions

FEBS Letters, EarlyView.
Circulating histones are emerging as promising biomarkers in critical illness due to their diagnostic, prognostic, and therapeutic potential. Detection methods such as ELISA and mass spectrometry provide reliable approaches for quantifying histone levels in plasma samples.
José Luis García‐Gimenez, Juan Carlos Ruiz‐Rodríguez, Ricard Ferrer, Raquel Durá, Antonio Artigas, Iván Bajaña, David Bolado López de Andujar, Irene Cánovas‐Cervera, Adrián Ceccato, Luis Chiscano‐Camón, Elena Climent‐Martinez, Georgia García Fernández, Gemma Goma, Verónica Monforte, Beatriz Quevedo‐Sánchez, Adolf Ruiz‐Sanmartín, Antonio Sierra‐Rivera, Nieves Carbonell Monleón   +17 more
wiley   +1 more source

Wearable cardioverter-defibrillator (life-vest): A feasible bridging treatment in adult congenital heart disease

Indian Pacing and Electrophysiology Journal, 2022
Background: Wearable cardioverter-defibrillators (WCDs) are currently used in patients at temporarily heightened risk for sudden cardiac death (SCD) who are temporarily unable to receive an implantable cardioverter-defibrillator (ICD).
Berardo Sarubbi, Michela Palma, Assunta Merola, Flavia Fusco, Anna Correra, Diego Colonna, Emanuele Romeo, Nicola Grimaldi, Giovanni Domenico Ciriello, Giancarlo Scognamiglio, Maria Giovanna Russo   +10 more
doaj  

Heart Disease Identification Method Using Machine Learning Classification in E-Healthcare

IEEE Access, 2020
Heart disease is one of the complex diseases and globally many people suffered from this disease. On time and efficient identification of heart disease plays a key role in healthcare, particularly in the field of cardiology.
J. Li, A. Haq, Salah Ud Din, Jalaluddin Khan, Asif Khan, Abdus Saboor   +5 more
semanticscholar   +1 more source

Heart to Heart, June 2013 [PDF]

, 2013
Heart to Heart is a publication on new heart disease and stroke information and other related topics by the Department of Public ...

core  

Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure [PDF]

, 2019
Heart failure is a leading cause of mortality, yet our understanding of the genetic interactions underlying this disease remains incomplete. Here, we harvest 1352 healthy and failing human hearts directly from transplant center operating rooms, and ...
Ashley, Euan A., Bernstein, Daniel, Brandimarto, Jeff, Cappola, Thomas, Chang, Alex C., Chin, Elizabeth T., Connolly, Andrew, Cordero, Pablo, Depaoli-Roach, Anna A., Dewey, Frederick, Erbilgin, Ayca, Glazer, Nicole, Gloudemans, Michael J., Hakonarson, Hakon, Hannenhalli, Sridhar, Huang, Yong, Li, Hongzhe, Li, Mingyao, Lusis, Aldons J., Malloy, Christine, Margulies, Kenneth B., Montgomery, Stephen B., Moravec, Christine S., Morley, Michael, Parikh, Victoria N., Pavlovic, Aleksandra, Ritter, Scott, Shang, Ching, Skreen, Jamie, Smith, Kevin S., Tang, W. H. Wilson, Waggott, Daryl, Wheeler, Matthew T., Zaleta, Kathia, Zhao, Mingming   +34 more
core   +2 more sources

Insights into pegRNA design from editing of the cardiomyopathy‐associated phospholamban R14del mutation

FEBS Letters, EarlyView.
This study reveals how prime editing guide RNA (pegRNA) secondary structure and reverse transcriptase template length affect prime editing efficiency in correcting the phospholamban R14del cardiomyopathy‐associated mutation. Insights support the design of structurally optimized enhanced pegRNAs for precise gene therapy.
Bing Yao, Qiangbing Yang, Christian J.B. Snijders Blok, Mark A. Daniels, Pieter A. Doevendans, Raymond Schiffelers, Joost P.G. Sluijter, Zhiyong Lei   +7 more
wiley   +1 more source

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention

Platelets, 2020
In patients with acute coronary syndrome (ACS), treatment using ticagrelor demonstrated significant ischemic benefits over clopidogrel; however, it was associated with increased bleeding complications leading to frequent de-escalation to clopidogrel. The
Chenggang Wang, Wen Zheng, Ayman Shaqdan, Chunmei Wang, Xiuchuan Qin, Xuedong Zhao, Xu Wang, Lin Yuan, Shaoping Nie, Ran Liu   +9 more
doaj   +1 more source

The “Fracking” technique: a novel approach to crack deep calcified plaque in the common femoral artery with hydraulic pressure

CVIR Endovascular, 2021
Background The patency achieved by conventional peripheral interventions for atherosclerotic lesions in the common femoral artery (CFA), called the “no stenting zone”, is not superior to that achieved by surgical endarterectomy due to calcified plaque ...
Takuya Haraguchi, Tsutomu Fujita, Yoshifumi Kashima, Masanaga Tsujimoto, Tsuyoshi Takeuchi, Yutaka Tadano, Daisuke Hachinohe, Umihiko Kaneko, Ken Kobayashi, Daitaro Kanno, Katsuhiko Sato   +10 more
doaj   +1 more source

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Journal of the American Medical Association (JAMA), 1998
CONTEXT Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal women who take estrogen than in women who do not, but this potential benefit has not been confirmed in clinical trials.
S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, E. Vittinghoff   +6 more
semanticscholar   +1 more source